Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

Pfizer set to commence phase III trials

From: Research

Positive mid-stage trial gives Allergy’s investors some welcome relief

A Pollinex packIts grass pollen vaccine showed a “highly significant” dose response

Articles

Pharmaceutical Market Europe - May 2018

We start off looking at the newly released 2018 edition of the Drugs to Watch Report, with 12 blockbusters predicted to launch this year. There is hope that some of these new drugs may help patients who are dealing with several of the most unmanageable diseases.

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

Dr Martin Rothman joins Sofinnova Partners

He becomes the firm’s venture partner

Rothman

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Getting the sizing right

Merger and Acquisition activity in our sector can learn from the natural world

darwins medicine

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics